What are the major opportunities in the Candidiasis Therapeutics market? What are the strategies for the Candidiasis Therapeutics market?

For detailed insights on the major opportunities and strategies in the Candidiasis Therapeutics market, Read More

How does the Candidiasis Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on Candidiasis Therapeutics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Candidiasis Therapeutics market growth? SWOT analysis of the Candidiasis Therapeutics market.

For detailed insights on the key dynamics influencing the Candidiasis Therapeutics market growth and SWOT analysis of the Candidiasis Therapeutics industry, Read More

Candidiasis Therapeutics Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Candidiasis Therapeutics Market Report 2026

Name: Candidiasis Therapeutics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Treatment Type (Medication, Supportive Therapy), By Anatomy Type (Oral Candidiasis, Vulvovaginal Candidiasis, Cutaneous Candidiasis, Invasive Candidiasis, Systemic Candidiasis), By Mode Of Administration (Injectable, Oral, Other Mode Of Administrations), By Patient Population (Adults, Pediatrics), By End User (Hospitals, Specialty Clinics, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Candidiasis Therapeutics Market Overview

• Candidiasis Therapeutics market size has reached to $3.29 billion in 2025

• Expected to grow to $4.03 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%

• Growth Driver: Rising Clinical Trials Fueling Advancements In Candidiasis Therapeutics Market

• Market Trend: Innovative Echinocandin Therapies Advancing Treatment Of Invasive Candida Infections

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Candidiasis Therapeutics Market?

Candidiasis is a fungal infection caused by the overgrowth of Candida species that naturally reside in the human body, particularly in the mouth, throat, gut, and genital area. Treatment for candidiasis typically involves antifungal medications, which can be topical (applied to the affected area) or oral (taken by mouth), depending on the severity and location of the infection.

The main types of treatments in candidiasis therapeutics are medication, surgery and others. Medication refers to the use of pharmaceutical drugs or substances to treat, manage, or alleviate medical conditions. It includes various anatomy types, such as oral candidiasis, vulvovaginal candidiasis, cutaneous candidiasis, invasive candidiasis, and systemic candidiasis, and it includes a variety of modes of administration, including injectable, oral and others, it is used by adults and pediatrics by various end-users, such as hospitals, homecare, specialty clinics, and other end-users.

Candidiasis Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Candidiasis Therapeutics Market Size and Share 2026?

The candidiasis therapeutics market size has grown steadily in recent years. It will grow from $3.29 billion in 2025 to $3.4 billion in 2026 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to increasing prevalence of immunocompromised patient populations, rising incidence of hospital-acquired fungal infections, widespread use of broad-spectrum antibiotics, availability of established antifungal drug classes, growth of hospital-based infectious disease care.

What Is The Candidiasis Therapeutics Market Growth Forecast?

The candidiasis therapeutics market size is expected to see steady growth in the next few years. It will grow to $4.03 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing research on novel antifungal drug classes, rising awareness of antifungal resistance management, expansion of outpatient antifungal treatment adoption, growing focus on pediatric candidiasis therapies, increasing investments in infectious disease drug development. Major trends in the forecast period include increasing development of targeted antifungal therapies, rising focus on early and accurate diagnosis, growing use of combination antifungal treatments, expansion of oral and systemic treatment options, enhanced monitoring of drug resistance patterns.

Book your 30 minutes free consultation with our research experts

Global Candidiasis Therapeutics Market Segmentation

1) By Treatment Type: Medication, Supportive Therapy

2) By Anatomy Type: Oral Candidiasis, Vulvovaginal Candidiasis, Cutaneous Candidiasis, Invasive Candidiasis, Systemic Candidiasis

3) By Mode Of Administration: Injectable, Oral, Other Mode Of Administrations

4) By Patient Population: Adults, Pediatrics

5) By End User: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Medication: Antifungal Drugs, Topical Treatments, Systemic Treatments

2) By Supportive Therapy: Probiotics, Symptom Management Therapies, Adjunct Nutritional Support

What Is The Driver Of The Candidiasis Therapeutics Market?

The increasing number of clinical trials is expected to propel the growth of the candidiasis therapeutics market going forward. Clinical trials are research studies conducted to evaluate the safety and effectiveness of new medical treatments, interventions, drugs, or devices in humans. Clinical trials play a pivotal role in the development of candidiasis therapeutics by providing a systematic and rigorous process to evaluate the safety and efficacy of potential treatments. For instance, in May 2023, according to ClinicalTrials.gov, a part of the National Institutes of Health (NIH), a US-based government agency responsible for conducting and supporting medical research, in 2023, around 437,533 clinical trials were registered, compared to 399,499 registered studies in 2022 in all 50 states of the United States and across 221 countries. Therefore, the increasing number of clinical trials is driving the growth of the candidiasis therapeutics industry.

Key Players In The Global Candidiasis Therapeutics Market

Major companies operating in the candidiasis therapeutics market are Pfizer Inc., Biocon Limited, Torrent Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, GSK plc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Cipla Inc., Lupin Limited, Basilea Pharmaceutica Ltd., WOCKHARDT Limited, Cidara Therapeutics Inc., Amplyx Pharmaceuticals Inc., SCYNEXIS Inc., Mycovia Pharmaceuticals Inc., NovaBiotics Inc., Matinas BioPharma Holdings Inc.

Global Candidiasis Therapeutics Market Trends and Insights

Major companies operating in the Candidiasis Therapeutics market are focusing on developing innovative solutions such as echinocandin antifungal therapy to improve treatment efficacy, reduce resistance, and enhance patient outcomes in managing invasive and systemic Candida infections. Echinocandin antifungal therapy is a class of drugs that inhibit ß-(1,3)-D-glucan synthesis in fungal cell walls, effectively treating serious invasive Candida infections. For instance, in March 2023, Cidara Therapeutics Inc., a US-based biotech company partnered with Melinta Therapeutics, a US-based biopharmaceutical company, received U.S. FDA approval for REZZAYO (rezafungin for injection) for the treatment of candidemia and invasive candidiasis in adults with limited or no alternative treatment options. REZZAYO is a novel once-weekly echinocandin antifungal, representing the first new treatment option for these infections in over a decade.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Candidiasis Therapeutics Market?

In May 2023, GSK plc, a UK-based pharmaceutical company, acquired Licensing rights for ibrexafungerp from Scynexism Inc. for $90 million. The acquisition provides GSK rights to develop and commercialize ibrexafungerp drugs, a first-in-class antifungal medication for treating vulvovaginal candidiasis (VVC), to accelerate the development and commercialization of ibrexafungerp. Scynexism Inc. is a US-based pharmaceutical company specializing in fungal disease therapies, including candidiasis.

Regional Outlook

North America was the largest region in the candidiasis therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Candidiasis Therapeutics Market?

The candidiasis therapeutics market consists of revenues earned by entities by providing services such as medication services, diagnostic tests, consultation services, and medical monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The candidiasis therapeutics market also includes sales of topical creams and ointments, oral medications, medical devices, probiotics, nutritional supplements and antifungal medications that are used in providing these services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Candidiasis Therapeutics Market Report 2026?

The candidiasis therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the candidiasis therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Candidiasis Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$3.4 billion
Revenue Forecast In 2035	$4.03 billion
Growth Rate	CAGR of 3.5% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment Type, Anatomy Type, Mode Of Administration, Patient Population, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Biocon Limited, Torrent Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, GSK plc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Cipla Inc., Lupin Limited, Basilea Pharmaceutica Ltd., WOCKHARDT Limited, Cidara Therapeutics Inc., Amplyx Pharmaceuticals Inc., SCYNEXIS Inc., Mycovia Pharmaceuticals Inc., NovaBiotics Inc., Matinas BioPharma Holdings Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Candidiasis Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Candidiasis Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Candidiasis Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Candidiasis Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increasing Development Of Targeted Antifungal Therapies

4.2.2 Rising Focus On Early And Accurate Diagnosis

4.2.3 Growing Use Of Combination Antifungal Treatments

4.2.4 Expansion Of Oral And Systemic Treatment Options

4.2.5 Enhanced Monitoring Of Drug Resistance Patterns

5. Candidiasis Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Homecare Providers

5.4 Pharmaceutical Companies

5.5 Diagnostic Laboratories

6. Candidiasis Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Candidiasis Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Candidiasis Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Candidiasis Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Candidiasis Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Candidiasis Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Candidiasis Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Candidiasis Therapeutics Market Segmentation

9.1. Global Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Medication, Supportive Therapy

9.2. Global Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Candidiasis, Vulvovaginal Candidiasis, Cutaneous Candidiasis, Invasive Candidiasis, Systemic Candidiasis

9.3. Global Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectable, Oral, Other Mode Of Administrations

9.4. Global Candidiasis Therapeutics Market, Segmentation By Patient Population, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adults, Pediatrics

9.5. Global Candidiasis Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Other End Users

9.6. Global Candidiasis Therapeutics Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antifungal Drugs, Topical Treatments, Systemic Treatments

9.7. Global Candidiasis Therapeutics Market, Sub-Segmentation Of Supportive Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Probiotics, Symptom Management Therapies, Adjunct Nutritional Support

10. Candidiasis Therapeutics Market Regional And Country Analysis

10.1. Global Candidiasis Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Candidiasis Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Candidiasis Therapeutics Market

11.1. Asia-Pacific Candidiasis Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Candidiasis Therapeutics Market

12.1. China Candidiasis Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Candidiasis Therapeutics Market

13.1. India Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Candidiasis Therapeutics Market

14.1. Japan Candidiasis Therapeutics Market Overview

14.2. Japan Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Candidiasis Therapeutics Market

15.1. Australia Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Candidiasis Therapeutics Market

16.1. Indonesia Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Candidiasis Therapeutics Market

17.1. South Korea Candidiasis Therapeutics Market Overview

17.2. South Korea Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Candidiasis Therapeutics Market

18.1. Taiwan Candidiasis Therapeutics Market Overview

18.2. Taiwan Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Candidiasis Therapeutics Market

19.1. South East Asia Candidiasis Therapeutics Market Overview

19.2. South East Asia Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Candidiasis Therapeutics Market

20.1. Western Europe Candidiasis Therapeutics Market Overview

20.2. Western Europe Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Candidiasis Therapeutics Market

21.1. UK Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Candidiasis Therapeutics Market

22.1. Germany Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Candidiasis Therapeutics Market

23.1. France Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Candidiasis Therapeutics Market

24.1. Italy Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Candidiasis Therapeutics Market

25.1. Spain Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Candidiasis Therapeutics Market

26.1. Eastern Europe Candidiasis Therapeutics Market Overview

26.2. Eastern Europe Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Candidiasis Therapeutics Market

27.1. Russia Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Candidiasis Therapeutics Market

28.1. North America Candidiasis Therapeutics Market Overview

28.2. North America Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Candidiasis Therapeutics Market

29.1. USA Candidiasis Therapeutics Market Overview

29.2. USA Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Candidiasis Therapeutics Market

30.1. Canada Candidiasis Therapeutics Market Overview

30.2. Canada Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Candidiasis Therapeutics Market

31.1. South America Candidiasis Therapeutics Market Overview

31.2. South America Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Candidiasis Therapeutics Market

32.1. Brazil Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Candidiasis Therapeutics Market

33.1. Middle East Candidiasis Therapeutics Market Overview

33.2. Middle East Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Candidiasis Therapeutics Market

34.1. Africa Candidiasis Therapeutics Market Overview

34.2. Africa Candidiasis Therapeutics Market, Segmentation By Treatment Type, Segmentation By Anatomy Type, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Candidiasis Therapeutics Market Regulatory and Investment Landscape

36. Candidiasis Therapeutics Market Competitive Landscape And Company Profiles

36.1. Candidiasis Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Candidiasis Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Candidiasis Therapeutics Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Biocon Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Torrent Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Candidiasis Therapeutics Market Other Major And Innovative Companies

AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, GSK plc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Cipla Inc., Lupin Limited, Basilea Pharmaceutica Ltd., WOCKHARDT Limited, Cidara Therapeutics Inc., Amplyx Pharmaceuticals Inc., SCYNEXIS Inc.

38. Global Candidiasis Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Candidiasis Therapeutics Market

40. Candidiasis Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Candidiasis Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Candidiasis Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Candidiasis Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Candidiasis Therapeutics Market, Overview Of Key Products - Product Examples

Table 2: Global Candidiasis Therapeutics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Candidiasis Therapeutics Market, Supply Chain Analysis

Table 4: Global Candidiasis Therapeutics Market, Major Raw Material Providers

Table 5: Global Candidiasis Therapeutics Market, Major Resource Providers

Table 6: Global Candidiasis Therapeutics Market, Major Manufacturers (Suppliers)

Table 7: Global Candidiasis Therapeutics Market, Major Distributors And Channel Partners

Table 8: Global Candidiasis Therapeutics Market, Key Technologies & Future Trends

Table 9: Global Candidiasis Therapeutics Market, Major Trends

Table 10: Global Candidiasis Therapeutics Market, Major End Users

Table 11: Global Candidiasis Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Candidiasis Therapeutics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Candidiasis Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Candidiasis Therapeutics Market - TAM, US$ Billion, 2025

Table 15: Global Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Candidiasis Therapeutics Market, Segmentation By Patient Population, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Candidiasis Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Candidiasis Therapeutics Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Candidiasis Therapeutics Market, Sub-Segmentation Of Supportive Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Candidiasis Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Candidiasis Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Candidiasis Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Candidiasis Therapeutics Market - Company Scoring Matrix

Table 98: Pfizer Inc. Financial Performance

Table 99: Biocon Limited Financial Performance

Table 100: Torrent Pharmaceuticals Ltd. Financial Performance

Table 101: F. Hoffmann-La Roche Ltd. Financial Performance

Table 102: Merck & Co. Inc. Financial Performance

Table 103: Global Candidiasis Therapeutics Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Candidiasis Therapeutics Market, Competitive Dashboard

Table 105: Global Candidiasis Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Candidiasis Therapeutics Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Table 107: Global, Candidiasis Therapeutics Market Size Gain ($ Billion), Segmentation By Anatomy Type, 2025 – 2030

Table 108: Global, Candidiasis Therapeutics Market Size Gain ($ Billion), Segmentation By Mode Of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Candidiasis Therapeutics Market, Overview Of Key Products - Product Examples

Figure 2: Global Candidiasis Therapeutics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Candidiasis Therapeutics Market, Supply Chain Analysis

Figure 4: Global Candidiasis Therapeutics Market, Major Raw Material Providers

Figure 5: Global Candidiasis Therapeutics Market, Major Resource Providers

Figure 6: Global Candidiasis Therapeutics Market, Major Manufacturers (Suppliers)

Figure 7: Global Candidiasis Therapeutics Market, Major Distributors And Channel Partners

Figure 8: Global Candidiasis Therapeutics Market, Key Technologies & Future Trends

Figure 9: Global Candidiasis Therapeutics Market, Major Trends

Figure 10: Global Candidiasis Therapeutics Market, Major End Users

Figure 11: Global Candidiasis Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Candidiasis Therapeutics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Candidiasis Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Candidiasis Therapeutics Market - TAM, US$ Billion, 2025

Figure 15: Global Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Candidiasis Therapeutics Market, Segmentation By Patient Population, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Candidiasis Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Candidiasis Therapeutics Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Candidiasis Therapeutics Market, Sub-Segmentation Of Supportive Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Candidiasis Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Candidiasis Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Candidiasis Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Candidiasis Therapeutics Market, Segmentation By Anatomy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Candidiasis Therapeutics Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Candidiasis Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Candidiasis Therapeutics Market - Company Scoring Matrix

Figure 98: Pfizer Inc. Financial Performance

Figure 99: Biocon Limited Financial Performance

Figure 100: Torrent Pharmaceuticals Ltd. Financial Performance

Figure 101: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 102: Merck & Co. Inc. Financial Performance

Figure 103: Global Candidiasis Therapeutics Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Candidiasis Therapeutics Market, Competitive Dashboard

Figure 105: Global Candidiasis Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Candidiasis Therapeutics Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Figure 107: Global, Candidiasis Therapeutics Market Size Gain ($ Billion), Segmentation By Anatomy Type, 2025 – 2030

Figure 108: Global, Candidiasis Therapeutics Market Size Gain ($ Billion), Segmentation By Mode Of Administration, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Hernia Mesh Devices Market Report 2026 - Global Outlook – By Mesh Type (Biologic Mesh, Synthetic Mesh), By Procedure (Open Surgeries, Laparoscopic Surgeries, Robotic Surgeries), By Hernia Type (Incisional Hernia, Umbilic...

Feed Pigment Market Report 2026 - Global Outlook – By Product (Carotenoids, Natural Yellow Pigments, Natural Red Pigments, Microalgae-Based Pigments, Other Products), By Source (Natural, Synthetic), By Livestock (Poultry...

Glassware Market Report 2026 - Global Outlook – By Material (Soda Lime Glass, Crystal Glass, Borosilicate Glass, Heat Resistant Glass), By Price Point (Premium, Medium, Economy), By Distribution Channel (Business-To-Busi...

Bot Security Market Report 2026 - Global Outlook – By Component (Solution, Services), By Security Type (Web Security, Mobile Security, Application Programming Interface (API) Security), By Deployment (Cloud-Based, On-Pre...

Automotive Data Cables Market Report 2026 - Global Outlook – By Cable (Controller Area Network (CAN), Low Voltage Differential Signaling (LVDS) Or High Speed Data (HSD), FlexRay, Ethernet, Controller Area Network Flexibl...

Antifungals Market Report 2026 - Global Outlook – By Drug Type (Echinocandins, Azoles, Polyenes, Allylamines ), By Route of Administration (Oral, Parenteral, Topical ), By End users (Hospitals & Clinics, Dermatology clin...

Biochips Market Report 2026 - Global Outlook – By Type (Deoxyribonucleic Acid (DNA) Chips, Protein Chips, Lab-On-Chip, Tissue Arrays, Cell Arrays), By Technology (Microarrays, Microfluidics), By Application (Drug Discove...

Frequently Asked Questions

How big is the Candidiasis Therapeutics Market?

The Candidiasis Therapeutics market was valued at $3.29 billion in 2025, increased to $3.4 billion in 2026, and is projected to reach $4.03 billion by 2030.

What is the Candidiasis Therapeutics market growth?

The global Candidiasis Therapeutics market is expected to grow at a CAGR of 4.3% from 2026 to 2035 to reach $4.03 billion by 2035.

Who are the key players in Candidiasis Therapeutics market?

Some Key Players in the Candidiasis Therapeutics market Include, Pfizer Inc., Biocon Limited, Torrent Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, GSK plc, Teva Ph

Major trend in this market includes: Innovative Echinocandin Therapies Advancing Treatment Of Invasive Candida Infections. For further insights on this market. request a sample here

North America was the largest region in the candidiasis therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the candidiasis therapeutics market report are Asia

Book your 30 minutes free consultation with our research experts

Contact Us